Effects of the NO-synthase Inhibitor VAS203 on Renal Function in Healthy Volunteers
Latest Information Update: 10 Jul 2023
At a glance
- Drugs Ronopterin (Primary)
- Indications Brain injuries; Renal impairment
- Focus Pharmacodynamics
- Sponsors vasopharm BIOTECH
- 24 Jun 2019 Results presented at the 29th European Meeting on Hypertension and Cardiovascular Protection
- 12 Jan 2019 Primary endpoint (Glomerular Filtration Rate) has been met as per results published in the British Journal of Clinical Pharmacology
- 12 Jan 2019 Primary endpoint (Renal plasma flow) has been met as per results published in the British Journal of Clinical Pharmacology